Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

Autor: Irene A. Malaty, Pablo Martinez-Martin, K. Ray Chaudhuri, Per Odin, Matej Skorvanek, Joohi Jimenez-Shahed, Michael J. Soileau, Susanna Lindvall, Josefa Domingos, Sarah Jones, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Koray Onuk, Lars Bergmann, Samira Femia, Michelle Y. Lee, Jack Wright, Angelo Antonini

Publikováno v: BMC Neurology, Vol 22, Iss 1, Pp 1-13 (2022)

Abstract Background The burden of Parkinson’s disease (PD) worsens with disease progression. However, the lack of objective and uniform disease classification challenges our understanding of the incremental burden in patients with advanced Parkinso

Externí odkaz: https://doaj.org/article/870078f6bdd4457eb525d8f5900a9200

Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)

Autor: Norbert Kovács, József Szász, Lydia Vela-Desojo, Per Svenningsson, Samira Femia, Juan Carlos Parra, Olga Sanchez-Soliño, Lars Bergmann, Tanya Gurevich, Alfonso Fasano

Publikováno v: Parkinsonismrelated disorders. 105

Patients with advanced Parkinson's disease (APD) commonly experience motor and nonmotor symptoms (NMS) associated with functional limitations and decreased quality of life. We compared motor and nonmotor outcomes in patients with APD receiving 24- ve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9433859936f277f595e79369b6c21652
https://pubmed.ncbi.nlm.nih.gov/36008198

Response to letter to the editor regarding "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries".

Autor: Antonini, Angelo¹ (AUTHOR), Chaudhuri, K. Ray² (AUTHOR), Domingos, Josefa^3,4 (AUTHOR), Jimenez-Shahed, Joohi⁵ (AUTHOR), Wright, Jack⁶ (AUTHOR), Yan, Connie H.⁷ (AUTHOR), Alobaidi, Ali⁷ (AUTHOR), Bergmann, Lars⁷ (AUTHOR), Onuk, Koray⁷ (AUTHOR), Harmer, Linda⁷ (AUTHOR), Malaty, Irene A.⁸ (AUTHOR) Irene.malaty@neurology.ufl.edu

Publikováno v: BMC Neurology. 7/30/2024, Vol. 24 Issue 1, p1-4. 4p.

Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study.

Autor: Evans A; Movement Disorders Program, Royal Melbourne Hospital, Australia., Fung VSC; Movement Disorders Unit, Department of Neurology, Westmead Hospital, Australia.; Sydney Medical School, University of Sydney, Australia., O'Sullivan JD; UQ Centre for Clinical Research, The University of Queensland, Australia.; Senior Visiting Neurologist Royal Brisbane & Women's Hospital, Australia., Stell R; Movement Disorders Clinic, Perron Institute, Australia., White R; Department of Neurology, Townsville Hospital, Australia., Williams DR; Van Cleef Roet Centre for Nervous Diseases, Australia., Femia S; Therapeutic Area Lead, AbbVie, United States of America., Onuk K; Study Designated Physician, AbbVie, United States of America.

Publikováno v: Clinical parkinsonism & related disorders [Clin Park Relat Disord] 2020 Oct 17; Vol. 4, pp. 100075. Date of Electronic Publication: 2020 Oct 17 (Print Publication: 2021).